Work

Non-BRAF targeted therapies for melanoma: protein kinase inhibitors in Phase II clinical trials

Year: 2014

Type: article

Source: Expert Opinion on Investigational Drugs

DOI: 10.1517/13543784.2014.884558

Authors: Shilpa Bhatia, Luni Emdad, Swadesh K Das, Hossein Hamed, Paul Dent, Devanand Sarkar, Paul B Fisher

Institutions: Virginia Commonwealth University, VCU Massey Comprehensive Cancer Center, Virginia Commonwealth University Medical Center

Language: English

Topic: Melanoma and MAPK Pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: G2953226657, Translational Applications of mda-7/IL-24 in Cancer, Pancreatic Cancer Management by Novel Gene Therapy & Dietary Agents, MDA-7: Novel Cancer Therapeutic Gene

OpenAlex ID: W2169624847

FWCI: 0.365

Cites: 82

Cited by: 3

Related to: 10